CDC puts Candida auris and Carbapenem-resistant Acinetobacter in urgent category

C. difficile, carbapenem-resistant Enterobacteriacese and drug-resistant Neisseria gonorrhoeae are also considered 'urgent'


The Centers for Disease Control and Prevention (CDC) recently released its report updating the state of infection prevalence and antibiotic-resistance threats, according to an article on the Infection Control Today website.

CDC categorizes pathogenic infection threats as concerning, serious, or urgent. Two superbugs have been newly placed in the urgent category: the fungus Candida auris and the bacteria carbapenem-resistant Acinetobacter (they join C. difficile, carbapenem-resistant Enterobacteriacese, and drug-resistant Neisseria gonorrhoeae).  

The report also revealed that more people have died from antibiotic-resistant infections than was previously believed. In 2013, the CDC estimated that 23,000 people a year die as a result of antibiotic-resistant germs. The new estimate is 44,000. 

Prevention methods seem to be working, however. Although the overall number of deaths each year is higher, the overall number of people dying from antibiotic-resistant infections has dropped since 2013. 

Read the article.



November 25, 2019


Topic Area: Infection Control


Recent Posts

UF Health Hospitals Rely on Green Globes to Realize Their Full Potential

Case study: The process encouraged the team to push themselves in several areas.


How Healthcare Facilities Can Be Truly Disaster-Resilient

Real resilience looks different than what’s written down in plans


TriasMD Breaks Ground on DISC Surgery Center for San Fernando Valley

It is set to open in Q3 2025


Bigfork Valley Hospital Falls Victim to Data Breach

The incident occurred in November 2024


AI-Driven Facilities: Strategic Planning and Cost Management 

6 factors to ensure infrastructure, operations and financial management support AI’s integration


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.